PART I Overview We are a publicly traded biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. Our proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. This advanced enveloped technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis,...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001493152-26-013242 | EDGAR | 145K words |
| 2025-03-31 | 2024-12-31 | 0001641172-25-001810 | EDGAR | — |
| 2024-03-15 | 2023-12-31 | 0001493152-24-010158 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001193125-23-088349 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001193125-22-090215 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001493152-25-022372 | EDGAR | 42K words |
| 2025-08-08 | 2025-06-30 | 0001641172-25-022797 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010317 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044833 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031688 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001493152-24-019305 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001493152-23-041122 | EDGAR | — |
| 2023-08-21 | 2023-06-30 | 0001193125-23-217072 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001193125-23-145095 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001193125-22-282874 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001193125-22-216531 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001193125-22-146662 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-31 | 0001493152-26-035666 | EDGAR | — |
| 2026-07-16 | 0001493152-26-033594 | EDGAR | — |
| 2026-04-02 | 0001493152-26-014951 | EDGAR | 1K words |
| 2026-03-27 | 0001493152-26-013236 | EDGAR | — |
| 2026-03-11 | 0001493152-26-009701 | EDGAR | — |
| 2026-02-10 | 0001493152-26-005840 | EDGAR | — |
| 2026-01-29 | 0001493152-26-004089 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022349 | EDGAR | — |
| 2025-11-10 | 0001493152-25-021418 | EDGAR | — |
| 2025-10-31 | 0001493152-25-020390 | EDGAR | — |
151 total filings indexed. 124 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001855485 |
| Ticker | CLDI |
| Exchange | NYSE |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.calidibio.com |
| Listed | 2023-09-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CLDI (~200 tokens, structured JSON with cryptographic provenance)